Mondelez is reportedly exploring a Hershey acquisition. Drugs like Ozempic could justify a deal.

Daily Trade

[unable to retrieve full-text content]

Articles You May Like

UnitedHealth shooting sparks security fears for execs — but fixes are expensive and complicated
‘Goldilocks’ Jobs Report Shows That a ‘Santa Rally’ Approaches
Big Tech’s data centers won’t get far unless the power grid is regulated less
The road to $100,000 — What’s behind bitcoin’s storied 2024 run
Billionaires have been beating the stock market — where they are putting their money now, according to UBS